Search

Your search keyword '"Molucon-Chabrot, Cécile"' showing total 24 results
Start Over Author "Molucon-Chabrot, Cécile"
24 results on '"Molucon-Chabrot, Cécile"'

1. Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study

Author

Lesueur, Paul, Damaj, Gandhi, Hoang-Xuan, Khê, Roland, Virginie, Schmitt, Anna, Chinot, Olivier, Fabbro, Michel, Agapé, Philippe, Moluçon-Chabrot, Cécile, Chebrek, Safia, Alentorn, Agusti, Feuvret, Loic, Delgadillo, Daniel, Stefan, Dinu, Choquet, Sylvain, Nichelli, Lucia, Mokhtari, Karima, Mathon, Bertrand, Dureau, Sylvain, Soussain, Carole, and Houillier, Caroline

Published
2022
Full Text
View/download PDF

2. Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study

Author

Bachy, Emmanuel, Houot, Roch, Feugier, Pierre, Bouabdallah, Krimo, Bouabdallah, Reda, Virelizier, Emmanuelle Nicolas, Maerevoet, Marie, Fruchart, Christophe, Snauwaert, Sylvia, Le Gouill, Steven, Marolleau, Jean-Pierre, Molina, Lysiane, Moluçon-Chabrot, Cécile, Thieblemont, Catherine, Tilly, Hervé, Bijou, Fontanet, Haioun, Corinne, Van den Neste, Eric, Fabiani, Bettina, Meignan, Michel, Cartron, Guillaume, Salles, Gilles, Casasnovas, Olivier, and Morschhauser, Franck

Published
2022
Full Text
View/download PDF

4. Human herpesvirus 6 infection after autologous stem cell transplantation: A multicenter prospective study in adult patients

Author

Balsat, Marie, Pillet, Sylvie, Tavernier, Emmanuelle, Cacheux, Victoria, Escuret, Vanessa, Moluçon-Chabrot, Cécile, Augeul-Meunier, Karine, Mirand, Audrey, Regagnon, Christel, Tinquaut, Fabien, Bousser, Véronique, Oriol, Mathieu, Guyotat, Denis, Salles, Gilles, Bay, Jacques-Olivier, Pozzetto, Bruno, and Cornillon, Jérôme

Published
2019
Full Text
View/download PDF

7. Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study

Author

Houillier, Caroline, Dureau, S, Taillandier, Luc, Houot, Roch, Chinot, O., Molucon-Chabrot, Cécile, Schmitt, Anna, Gressin, Rémy, Choquet, Sylvain, Damaj, Gandhi, Peyrade, Frédéric, Abraham, Julie, Delwail, V, Gyan, Emmanuel, Sanhes, Laurence, Cornillon, Jerome, Garidi, Reda, Delmer, Alain, Al Jijakli, Ahmad, Morel, Pierre, Waultier, Agathe, Paillassa, Jérôme, Chauchet, A, Gastinne, Thomas, Laadhari, Mouna, Plissonnier, Anne-Sophie, Feuvret, Loïc, Cassoux, Nathalie, Touitou, Valerie, Ricard, Jean-Damien, Hoang-Xuan, Khe, Soussain, Carole, Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Institut Curie [Paris], Centre Hospitalier Universitaire de Nancy (CHU Nancy), Microenvironment and B-cells: Immunopathology,Cell Differentiation, and Cancer (MOBIDIC), Université de Rennes (UR)-Etablissement français du sang [Rennes] (EFS Bretagne)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Hôpital de la Timone [CHU - APHM] (TIMONE), CHU Louise Michel [Clermont-Ferrand], CHU Clermont-Ferrand, Institut Bergonié [Bordeaux], UNICANCER, Centre Hospitalier Universitaire [Grenoble] (CHU), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), CHU Amiens-Picardie, Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), CHU Limoges, CIC - Poitiers, Université de Poitiers-Centre hospitalier universitaire de Poitiers (CHU Poitiers)-Direction Générale de l'Organisation des Soins (DGOS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d’Investigation Clinique [Tours] CIC 1415 (CIC ), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau-Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Saint Jean de Perpignan, Institut de Cancérologie Lucien Neuwirth, Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), Centre Hospitalier Universitaire de Reims (CHU Reims), Centre Hospitalier de Lens, Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Centre hospitalier universitaire de Nantes (CHU Nantes), Hôpital d'instruction des Armées Percy, Service de Santé des Armées, Immunité et cancer (U932), and Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
Adult, Cancer Research, Adolescent, Lymphoma, [SDV]Life Sciences [q-bio], Hematopoietic Stem Cell Transplantation, Middle Aged, Transplantation, Autologous, Combined Modality Therapy, Central Nervous System Neoplasms, Young Adult, Oncology, Antineoplastic Combined Chemotherapy Protocols, Humans, Neoplasm Recurrence, Local
Abstract

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. We previously reported the results of a randomized phase II study in patients with newly diagnosed primary CNS lymphoma (age 18-60 years). Patients were treated with high-dose methotrexate-based induction chemotherapy followed by whole-brain radiotherapy (WBRT) or high-dose chemotherapy (thiotepa-busulfan-cyclophosphamide) with autologous stem-cell transplantation (ASCT). The median follow-up was 33 months. In this report, we provide long-term data (median follow-up, 8 years) regarding the outcomes and toxicities. Fifty-three and 44 patients received induction chemotherapy followed by WBRT or ASCT, respectively. Their 8-year event-free survival from random assignment was 67% and 39% in the ASCT and WBRT arms, respectively ( P = .03), with a significantly lower risk of relapse after ASCT (hazard ratio, 0.13; P < .001). One third of patients who relapsed after WBRT were alive after salvage treatment. Five and four patients died of ASCT and WBRT-related toxicities, respectively. The 8-year overall survival was 69% and 65% in the ASCT and WBRT arms, respectively (not significant). Balance (52% v 10%, P ≤ 0.001) and neurocognition (64% v 13%, P < .001) significantly deteriorated after WBRT compared with ASCT during the follow-up. This study shows that 40 Gy WBRT should be avoided in first-line treatment because of its neurotoxicity and suboptimal efficacy in reducing relapses while ASCT appears to be highly efficient in preventing relapses.

Published
2022
Full Text
View/download PDF

9. High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years

Author

Gyan, Emmanuel, Foussard, Charles, Bertrand, Philippe, Michenet, Patrick, Le Gouill, Steven, Berthou, Christian, Maisonneuve, Hervé, Delwail, Vincent, Gressin, Rémi, Quittet, Philippe, Vilque, Jean-Pierre, Desablens, Bernard, Jaubert, Jérôme, Ramée, Jean-François, Arakelyan, Nina, Thyss, Antoine, Moluçon-Chabrot, Cécile, Delépine, Roselyne, Milpied, Noël, Colombat, Philippe, and Deconinck, Eric

Published
2009
Full Text
View/download PDF

10. Atgam Efficacy and Safety in Moderate-to-Very Severe Acquired Aplastic Anemia: Outcome of a Large Multicenter Cohort of 634 Children and Adults from the French Authorization for Temporary Use Surveillance Program

Author

Sicre De Fontbrune, Flore, Fahd, Mony, Forcade, Édouard, Tavitian, Suzanne, Moluçon Chabrot, Cécile, Barraco, Fiorenza, Hicheri, Yosr, Lebon, Delphine, Maury, Sébastien, Menard, Anne-Lise, Możejko-Pastewka, Barbara, Wolter, Kevin D, Valtier, Bruno, Leblanc, Thierry, and Peffault De Latour, Regis

Published
2023
Full Text
View/download PDF

11. Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Author

Letestu, Rémi, Dahmani, Abdelmalek, Boubaya, Marouane, Baseggio, Lucile, Campos, Lydia, Chatelain, Bernard, Debliquis, Agathe, Drénou, Bernard, Jacob, Marie-Christine, Legac, Eric, Le Garff-Tavernier, Magali, Lhoumeau, Anne-Catherine, Quiney, Claire, Robillard, Nelly, Ticchioni, Michel, Aanei, Carmen, Katsahian, Sandrine, Delepine, Roselyne, Vaudaux, Sandrine, Rouillé, Valérie, Béné, Marie-Christine, Dartigeas, Caroline, Van Den Neste, Eric, Leprêtre, Stéphane, Feugier, Pierre, Cartron, Guillaume, Leblond, Véronique, Lévy, Vincent, Cymbalista, Florence, Cailleres, Sylvie, Damaj, Gandhi, Royer, Bruno, Gardembas, Martine, Dib, Mamoun, Truchan-Graczyk, Matgorzata, Hunault, Mathilde, Foussard, Charles, Corront, Bernadette, Parry, Anne, Orsini-Piocelle, Frédérique, Trouillier, Sébastien, Slama, Bohiane, Lepeu, Gérard, Zerazhi, Hacene, Boulat, Olivier, Azzedine, Ahmed, Araujo, Carla, Banos, Anne, Bauduer, Frédéric, Dutel, Jean-Luc, Ghomari, Kamel, Deconinck, Eric, Brion, Annie, Vuillier, Jacqueline, Saad, Alain, El Yamani, Abderrazak, Rodon, Philippe, Soubeyran, Pierre, Etienne, Gabriel, Dilhuydy, Marie-Sarah, Bouabdallah, Krimo, Leguay, Thibaut, Chouffi, Bachra, Pollet, Bertrand, Maakaroun, Abdallah, Guillerm, Gaëlle, Berthou, Christian, Cheron, Nathalie, ANDRÉ, Marc, Vilque, Jean Pierre, Fruchart, Christophe, Voillat, Laurent, Pica, Gian Matteo, Corm, Sélim, Micléa, Jean-Michel, Souleau, Bertrand, Molucon-Chabrot, Cécile, De Renzis, Benoit, Tournilhac, Olivier, Bay, Jacques-Olivier, Chaleteix, Carine, Guieze, Romain, Fleury, Joel, Precupanu, Cristina, Bouledroua, Selwa, Haiat, Stéphanie, Petitdidier, Charlotte, Dupuis, Jehan, Belhadj, Karim, Casasnovas, Olivier, Bastie, Jean-Noel, Ferrant, Emmanuelle, Gholam, Dany, Molina, Lysiane, Garban, Frédéric, Tiab, Mourad, Maisonneuve, Hervé, Villemagne, Bruno, Jacomy, Dominique, Besson, Caroline, Tertian, Gérard, Laribi, Kamel, Morel, Pierre, Cazin, Bruno, Moreau, Stéphane, Reminieras, Liliane, Rapp, Marie-José, Moreau, Philippe, Sebban, Catherine, Michallet, Anne-Sophie, Salles, Gilles, Broussais, Florence, Aurran-Schleinitz, Thérèse, Coso, Diane, Abarah, Wajed, Kulekci, Claire, Dorvaux, Véronique, Carassou, Philippe, Guibaud, Isabelle, Christian, Bernard, Graux, Carlos, Rossi, Jean-François, Quittet, Philippe, Dubois, Alain, Eisenmann, Jean-Claude, Morineau, Nadine, Mahé, Béatrice, Karsenti, Jean-Michel, Jourdan, Eric, Legouffe, Eric, Alexis-Vigier, Magda, Boulet, Jean-Michel, Aoudjhane, Malek, Thiéblemont, Catherine, Andreoli, Anna Lisa, Dreyfus, François, Choquet, Sylvain, Maloum, Karim, Merle-Béral, Hélène, Vekhoff, Anne, Decaudin, Didier, Brault, Philippe, Delarue, Richard, Janvier, Maud, Soussain, Carole, Vallantin, Xavier, Sanhes, Laurence, Dreyfus, Brigitte, Tomowiak, Cécile, Benramdane, Riad, Gonzalez, Hugo, Blaise-Brenna, Anne, Kolb, Brigitte, Delmer, Alain, Dauriac, Charles, Houot, Roch, Escoffre-Barbe, Martine, Lamy, Thierry, De Guibert, Sophie, Bernard, Marc, Grosbois, Bernard, Brehar, Oana, Morice, Patrick, Guyotat, Denis, Jaubert, Jérome, Portois, Christelle, Fornecker, Luc-Matthieu, Herbrecht, Raoul, Bilger, Karin, Ame, Shanti, Ysebaert, Loic, Godmer, Pascal, Jardel, Henry, Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), CHU Saint-Etienne, CHU UCL Namur, Groupe hospitalier de la région de Mulhouse Sud-Alsace (GHRMSA), CHU Grenoble, Centre Hospitalier Régional d'Orléans (CHRO), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre hospitalier universitaire de Nantes (CHU Nantes), Centre Hospitalier Universitaire de Nice (CHU Nice), Hopital Saint-Louis [AP-HP] (AP-HP), Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université Catholique de Louvain = Catholic University of Louvain (UCL), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Université de Montpellier (UM), UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - SSS/DDUV/BCHM - Biochimie-Recherche métabolique, UCL - (MGD) Laboratoire de biologie clinique, UCL - (SLuc) Service d'hématologie, Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), and Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)

Subjects
0301 basic medicine, Male, Cancer Research, Neoplasm, Residual, MESH: Immunotherapy, Chronic lymphocytic leukemia, Gastroenterology, MESH: Clinical Trials, Phase III as Topic, 0302 clinical medicine, Bone Marrow, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, MESH: Leukemia, Lymphocytic, Chronic, B-Cell, MESH: Aged, education.field_of_study, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Hematology, MESH: Follow-Up Studies, Prognosis, 3. Good health, Fludarabine, Survival Rate, Leukemia, MESH: Antineoplastic Combined Chemotherapy Protocols, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, MESH: Vidarabine, MESH: Bone Marrow, Female, MESH: Rituximab, Immunotherapy, Rituximab, MESH: Clinical Trials, Phase II as Topic, Vidarabine, medicine.drug, medicine.medical_specialty, Cyclophosphamide, MESH: Survival Rate, Population, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Prognosis, 03 medical and health sciences, Clinical Trials, Phase II as Topic, Chemoimmunotherapy, Internal medicine, medicine, Humans, education, Survival rate, MESH: Neoplasm, Residual, Aged, Retrospective Studies, MESH: Humans, business.industry, MESH: Cyclophosphamide, MESH: Retrospective Studies, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, MESH: Male, body regions, 030104 developmental biology, Clinical Trials, Phase III as Topic, Bone marrow, business, MESH: Female, Follow-Up Studies
Abstract

International audience; Measurable residual disease (MRD) status is widely adopted in clinical trials in patients with chronic lymphocytic leukemia (CLL). Findings from FILO group trials (CLL2007FMP, CLL2007SA, CLL2010FMP) enabled investigation of the prognostic value of high-sensitivity (0.7 × 10-5) MRD assessment using flow cytometry, in blood (N = 401) and bone marrow (N = 339), after fludarabine, cyclophosphamide, and rituximab (FCR)-based chemoimmunotherapy in a homogeneous population with long follow-up (median 49.5 months). Addition of low-level positive MRD

Published
2020
Full Text
View/download PDF

12. Radiotherapy (WBRT) or Autologous Stem-Cell Transplantation (ASCT) for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Long-Term Results of the Intergroup Anocef-Goelams Randomized Phase II Precis Study

Author

Houillier, Caroline, Taillandier, Luc, Houot, Roch, Chinot, Olivier, Molucon-Chabrot, Cecile, Schmitt, Anna, Gressin, Rémy, Sylvain, Choquet, Damaj, Gandhi Laurent, Abraham, Julie, Delwail, Vincent, Gyan, Emmanuel, Dureau, Sylvain, Sanhes, Laurence, Cornillon, Jérôme, Garidi, Reda, Delmer, Alain, Tanguy, Marie-laure, AL Jijakli, Ahmad Kanj, Morel, Pierre, Moles, Marie-Pierre, Chauchet, Adrien, Gastinne, Thomas, Feuvret, Loïc, Cassoux, Nathalie, Touitou, Valerie, Ricard, Damien, Peyrade, Frédéric, Laadhari, Mouna, Plissonnier, Anne-Sophie, Hoang-Xuan, Khe, and Soussain, Carole

Published
2021
Full Text
View/download PDF

13. Primary Diffuse Large B-Cell CNS Lymphoma over 80 Years: An Analysis of 110 Patients from the French Oculo-Cerebral Lymphoma (LOC) Network

Author

Maarek, Alizee, Maucort-Boulch, Delphine, Houillier, Caroline, Chinot, Olivier, Bijou, Fontanet, Taillandier, Luc, Agape, Philippe, Houot, Roch, Boyle, Eileen, Molucon-Chabrot, Cecile, Rey, Philippe, Choquet, Sylvain, Tamburini Bonnefoy, Jerome, Jaccard, Arnaud, Ahle, Guido, Fabbro, Michel, Gac, Anne-Claire, Meniane, Jean-Come, Le Coz, Marie Francoise, Gyan, Emmanuel, Hoang-Xuan, Khe, Soussain, Carole, and Ghesquieres, Herv

Published
2018
Full Text
View/download PDF

14. Aplastic Anemia in the Elderly: A Nationwide Survey on Behalf of the French Reference Center for Aplastic Anemia

Author

Contejean, Adrien, Resche-Rigon, Matthieu, Tamburini, Jérôme, Alcantara, Marion, Jardin, Fabrice, Lengline, Etienne, Ades, Lionel, Bouscary, Didier, Marçais, Ambroise, Lebon, Delphine, Moluçon-Chabrot, Cécile, Terriou, Louis, Barraco, Fiorenza, Banos, Anne, Bussot, Lucile, Cahn, Jean-Yves, Hirsch, Pierre, Maillard, Natacha, Simon, Laurence, Fornecker, Luc Mathieu, Socie, Gerard, Peffault De Latour, Regis, and Sicre De Fontbrune, Flore

Published
2018
Full Text
View/download PDF

15. A Phase II Lysa Study of Obinutuzumab Combined with Lenalidomide for Advanced Untretated Follicular B-Cell Lymphoma in Need of Systemic Therapy

Author

Morschhauser, Franck, Salles, Gilles Andre, Casasnovas, Rene-Olivier, Feugier, Pierre, Bouabdallah, Krimo, Cartron, Guillaume, Bouabdallah, Reda, Nicolas-Virelizier, Emmanuelle, Maerevoet, Marie, Snauwaert, Sylvia, Fruchart, Christophe, LE Gouill, Steven, Moluçon-Chabrot, Cécile, Delette, Caroline, Molina, Lysiane, Tilly, Herve, Thieblemont, Catherine, Van Den Neste, Eric, Bijou, Fontanet, Fabiani, Bettina, Haioun, Corinne, and Houot, Roch

Published
2018
Full Text
View/download PDF

17. A Phase II LYSA Study of Obinutuzumab Combined with Lenalidomide for Relapsed or Refractory Aggressive B-Cell Lymphoma

Author

Morschhauser, Franck, Cartron, Guillaume, Salles, Gilles A., Bijou, Fontanet, Fruchart, Christophe, Bouabdallah, Krimo, Feugier, Pierre, Le Gouill, Steven, Tilly, Hervé, moluçon-Chabrot, Cecile, Maerevoet, Marie, Casasnovas, Rene-Olivier, Van Den Neste, Eric W, Zachee, Pierre, Van Eygen, Koen, Van Hoof, Achiel, Bonnet, Christophe, Haioun, Corinne, Andre, Marc, Xerri, Luc, and Houot, Roch

Published
2016
Full Text
View/download PDF

19. Ibrutinib Monotherapy in Relapse or Refractory Primary CNS Lymphoma (PCNSL) and Primary Vitreo-Retinal Lymphoma (PVRL). Result of the Interim Analysis of the iLOC Phase II Study from the Lysa and the French LOC Network

Author

Choquet, Sylvain, Houillier, Caroline, Bijou, Fontanet, Houot, Roch, Boyle, Eileen, Gressin, Remy, Nicolas-Virelizier, Emmanuelle, Barrie, Maryline, Molucon-Chabrot, Cecile, Blonski, Marie, El Yamani, Abderrazak, LeLez, Marie-Laure, Clavert, Aline, Coisy, Solène, Ertault de la Bretonnière, Marjan, Touitou, Valérie, Cassoux, Nathalie, Boussetta, Sami, Broussais, Florence, Gelas-Dore, Benedicte, Barzic, Noélie, Ghesquieres, Herve, Hoang-Xuan, Khê, and Soussain, Carole

Published
2016
Full Text
View/download PDF

20. Whole Brain Radiotherapy (WBRT) Versus Intensive Chemotherapy with Haematopoietic Stem Cell Rescue (IC + HCR) for Primary Central Nervous System Lymphoma (PCNSL) in Young Patients: An Intergroup Anocef-Goelams Randomized Phase II Trial (PRECIS)

Author

Houillier, Caroline, Taillandier, Luc, Lamy, Thierry, Chinot, Olivier, Molucon-Chabrot, Cecile, Soubeyran, Pierre, Gressin, Remy, Choquet, Sylvain, Damaj, Gandhi, Thyss, Antoine, Jaccard, Arnaud, Delwail, Vincent, Gyan, Emmanuel, Sanhes, Laurence, Cornillon, Jerome, Garidi, Reda, Delmer, Alain, Savignoni, Alexia, AL Jijakli, Ahmad, Morel, Pierre, Bourquard, Pascal, Moles, Marie-Pierre, Deconinck, Eric, Gastinne, Thomas, Constans, Jean-Marc, Langer, Adriana, Lacomblez, Lucette, Delgadillo, Daniel, Dureau, Sylvain, Turbiez, Isabelle, Plissonnier, Anne-Sophie, Cassoux, Nathalie, Touitou, Valérie, Ricard, Damien, Hoang-Xuan, Khê, and Soussain, Carole

Published
2016
Full Text
View/download PDF

21. Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a "Proof of Concept" Phase II Study of the French LOC Network

Author

Ghesquieres, Herve, Houillier, Caroline, Chinot, Olivier, Choquet, Sylvain, Molucon-Chabrot, Cecile, Beauchene, Patrick, Gressin, Remy, Morschhauser, Franck, Schmitt, Anna, Gyan, Emmanuel, Hoang-Xuan, Khê, Nicolas-Virelizier, Emmanuelle, Chevrier, Marion, Savignoni, Alexia, Turbiez, Isabelle, Veillas, Florence, Soumelis, Vassili, and Soussain, Carole

Published
2016
Full Text
View/download PDF

22. Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis

Author

Molucon-Chabrot, Cécile, primary, Isambert, Nicolas, additional, Benoit, Laurent, additional, Zanetta, Sylvie, additional, Fraisse, Jean, additional, Guilland, Jean-Claude, additional, Royer, Bernard, additional, Monin-Baroille, Pascale, additional, Flesch, Michel, additional, Fargeot, Pierre, additional, Coudert, Bruno, additional, Mayer, Françoise, additional, Fumoleau, Pierre, additional, and Chauffert, Bruno, additional

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results